Pharmaceutical Industry

Johnson & Johnson tops Wall Street estimates on strong drug sales

U.S. FDA declines to approve Orexo’s opioid overdose drug

Pfizer moves forward with once-daily weight-loss pill

Pfizer plans to move forward with once-daily weight loss pill

Brookfield teams up with Spain’s Grifols family to explore a bid for Spanish drug maker

Eli Lilly to buy bowel disease drug developer Morphic for US$3.2-billion

Novo Nordisk reprimanded in U.K. for failing to disclose payments to health care sector

GSK buys COVID, influenza vaccines from retrenching CureVac

U.S. FDA approves second Alzheimer’s drug that can modestly slow disease

Authorities shutter Vancouver pharmacy citing multiple violations of federal drug laws

U.S. Supreme Court rejects nationwide opioid settlement with OxyContin maker Purdue Pharma

Quebec pharmacists association seeks class-action lawsuit over practice of ‘steering patients’ to certain pharmacies

JAMP Pharma Group to acquire 100,000 square feet of Pharmalab Inc. manufacturing space

Drugmakers set to raise U.S. prices on at least 500 drugs in January

Ten per cent of prescription drugs linked to support programs sponsored by pharmaceutical companies: study

Health Canada to review U.S. panel’s conclusion that common decongestant doesn’t work

Naloxone kits across Canada should have both nasal spray and injection options, panel says

10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions

Cannabis company Atlantic Cultivation acquires insolvent Tantalus Labs brand

Government signs new deal on generic drug pricing with pharmaceutical industry